02171.HK
CARsgen Therapeutics Holdings Limited
HKSE · Healthcare · Biotechnology · CN
HKD 13.43
+2.36%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 20.44x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.09x
- Price / sales
- 32.20x
- Price / cash flow
- -16.30x
Enterprise value
- Enterprise value
- HKD 6.2B
- EV / sales
- 25.77x
- EV / EBITDA
- -8.24x
- EV / EBIT
- -8.26x
- Market cap
- HKD 7.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026